Cargando…

Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals

Charge heterogeneity profiling is important for the quality control (QC) of biopharmaceuticals. Because of the increasing complexity of these therapeutic entities [1], the development of alternative analytical techniques is needed. In this work, flow‐through partial‐filling affinity capillary electr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutanu, Andrei, Kiessig, Steffen, Bathke, Andrea, Ketterer, Rolf, Riner, Sonja, Olaf Stracke, Jan, Wild, Markus, Moritz, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900010/
https://www.ncbi.nlm.nih.gov/pubmed/31560789
http://dx.doi.org/10.1002/elps.201900233
_version_ 1783477259856773120
author Hutanu, Andrei
Kiessig, Steffen
Bathke, Andrea
Ketterer, Rolf
Riner, Sonja
Olaf Stracke, Jan
Wild, Markus
Moritz, Bernd
author_facet Hutanu, Andrei
Kiessig, Steffen
Bathke, Andrea
Ketterer, Rolf
Riner, Sonja
Olaf Stracke, Jan
Wild, Markus
Moritz, Bernd
author_sort Hutanu, Andrei
collection PubMed
description Charge heterogeneity profiling is important for the quality control (QC) of biopharmaceuticals. Because of the increasing complexity of these therapeutic entities [1], the development of alternative analytical techniques is needed. In this work, flow‐through partial‐filling affinity capillary electrophoresis (FTPFACE) has been established as a method for the analysis of a mixture of two similar monoclonal antibodies (mAbs). The addition of a specific ligand results in the complexation of one mAb in the co‐formulation, thus changing its migration time in the electric field. This allows the characterization of the charged variants of the non‐shifted mAb without interferences. Adsorption of proteins to the inner capillary wall has been circumvented by rinsing with guanidine hydrochloride before each injection. The presented FTPFACE approach requires only very small amounts of ligands and provides complete comparability with a standard CZE of a single mAb.
format Online
Article
Text
id pubmed-6900010
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69000102019-12-20 Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals Hutanu, Andrei Kiessig, Steffen Bathke, Andrea Ketterer, Rolf Riner, Sonja Olaf Stracke, Jan Wild, Markus Moritz, Bernd Electrophoresis Part V. Proteins, Proteomics and 2D Charge heterogeneity profiling is important for the quality control (QC) of biopharmaceuticals. Because of the increasing complexity of these therapeutic entities [1], the development of alternative analytical techniques is needed. In this work, flow‐through partial‐filling affinity capillary electrophoresis (FTPFACE) has been established as a method for the analysis of a mixture of two similar monoclonal antibodies (mAbs). The addition of a specific ligand results in the complexation of one mAb in the co‐formulation, thus changing its migration time in the electric field. This allows the characterization of the charged variants of the non‐shifted mAb without interferences. Adsorption of proteins to the inner capillary wall has been circumvented by rinsing with guanidine hydrochloride before each injection. The presented FTPFACE approach requires only very small amounts of ligands and provides complete comparability with a standard CZE of a single mAb. John Wiley and Sons Inc. 2019-10-08 2019-11 /pmc/articles/PMC6900010/ /pubmed/31560789 http://dx.doi.org/10.1002/elps.201900233 Text en © 2019 The Authors. Electrophoresis published by Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Part V. Proteins, Proteomics and 2D
Hutanu, Andrei
Kiessig, Steffen
Bathke, Andrea
Ketterer, Rolf
Riner, Sonja
Olaf Stracke, Jan
Wild, Markus
Moritz, Bernd
Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals
title Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals
title_full Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals
title_fullStr Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals
title_full_unstemmed Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals
title_short Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals
title_sort application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals
topic Part V. Proteins, Proteomics and 2D
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900010/
https://www.ncbi.nlm.nih.gov/pubmed/31560789
http://dx.doi.org/10.1002/elps.201900233
work_keys_str_mv AT hutanuandrei applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals
AT kiessigsteffen applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals
AT bathkeandrea applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals
AT kettererrolf applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals
AT rinersonja applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals
AT olafstrackejan applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals
AT wildmarkus applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals
AT moritzbernd applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals